Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts, Latvijas Biomedicīnas Pētījumu Un Studiju CentrsfiledCriticalLatvijas Organiskās Sintēzes Institūts
Priority to LVP-13-02ApriorityCriticalpatent/LV14884B/en
Publication of LV14884ApublicationCriticalpatent/LV14884A/en
Publication of LV14884BpublicationCriticalpatent/LV14884B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Pyridine Compounds
(AREA)
Abstract
The present invention pertains to the field of biochemistry and medicine, particularly to derivatives of 1,4-dihydropyridin-4-yl-piridynium salts as modulators of adenosine A2A receptors useable in medicine for prevention of inflammatory processes related pathologies, for treatment of COPD, diabetic ulcers as well as for regulation of arterial pressure.
LVP-13-02A2013-01-172013-01-171,4-dihydropyridin-4-yl-piridynium salts as novel ago-allosteric modulators of adenosine a2a receptors
LV14884B
(en)